BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27441820)

  • 1. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of GastroPanel in the diagnosis of atrophic gastritis.
    Grad C; Pop A; Gaborean E; Grad S; Dumitrascu D
    Exp Ther Med; 2021 Nov; 22(5):1347. PubMed ID: 34630701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological assessment of gastric mucosal atrophy in gastric cancer.
    Bornschein J; Selgrad M; Wex T; Kuester D; Malfertheiner P
    BMC Gastroenterol; 2012 Jan; 12():10. PubMed ID: 22289789
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wu M; Feng S; Qian M; Wang S; Zhang K
    Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of biologic parameters in Helicobacter pylori gastritis: comparison with histological results].
    Abaza H; Ghanem A; Karoui J; Jmal A; Dhouib R; Harzallah L; Ben Mami N; Khaled R; Guemira F
    Ann Biol Clin (Paris); 2010; 68(4):473-9. PubMed ID: 20650743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
    Cheng HC; Tsai YC; Yang HB; Yeh YC; Chang WL; Kuo HY; Lu CC; Sheu BS
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28326664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
    Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
    Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development.
    Hara D; Okamura T; Iwaya Y; Nagaya T; Ota H; Umemura T
    Helicobacter; 2022 Dec; 27(6):e12934. PubMed ID: 36263778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
    Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
    Wang X; Zhang Q; Han F; Wu Y
    Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
    [No Abstract]   [Full Text] [Related]  

  • 19. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
    Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
    World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan.
    Kawamura M; Uedo N; Koike T; Kanesaka T; Hatta W; Ogata Y; Oikawa T; Iwai W; Yokosawa S; Honda J; Asonuma S; Okata H; Ohyauchi M; Ito H; Abe Y; Ara N; Kayaba S; Shinkai H; Shimokawa T
    Dig Endosc; 2022 Mar; 34(3):508-516. PubMed ID: 34415621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.